A lack of ethnic diversity among donors, coupled with cultural myths, have led to a paucity of bone marrow donors, resulting in hundreds of avoidable deaths caused by leukaemia and other blood-related diseases. According to Jane Ward, the deputy director of the South African Bone Marrow Registry (SABMR), the lack of sufficient education to counter cultural beliefs, especially among black South Africans, contributes to donor resistance
Over the past decade, the CRISPR-Cas9 gene editing system has revolutionized genetic engineering, allowing scientists to make targeted changes to organisms DNA. While the system could potentially be useful in treating a variety of diseases, CRISPR-Cas9 editing involves cutting DNA strands, leading to permanent changes to the cells genetic material. Now, in a paper published online in Cell on April 9, researchers describe a new gene editing technology called CRISPRoff that allows researchers to control gene expression with high specificity while leaving the sequence of the DNA unchanged.
Get Sample Report Buy Complete Report Adult Stem Cells Market research is an intelligence report with meticulous efforts undertaken to study the right and valuable information. The data which has been looked upon is done considering both, the existing top players and the upcoming competitors. Business strategies of the key players and the new entering market industries are studied in detail.
Global Adult Stem Cells Market Analysis 2020-2025 | Competitors analysis, Growth status, and Business opportunities A Comprehensive market intelligence report on the Global Adult Stem Cells Market works best for advanced and secondary research shows the competitive landscape and the conspicuous market players expected to lead the Adult Stem Cells Market for the forecast period, 2020-2025. The study not only shots through the company profile of the major dealers but also analyses their winning tactics to give industry owners, stakeholders including field marketing personnel a competitive edge over others operating in the same space. In 2020, the market size of Adult Stem Cells is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2020; Download Free Sample Report (Including COVID-19 Impact Analysis) The final report will add the analysis of the Impact of Covid-19 in this report Hazelnut Market.
Creating new sourcing, EryPharm envisions delivering red blood cells for transfusion. PARIS--(BUSINESS WIRE)-- EryPharm, startup created in 2016, has achieved a revolutionary technological breakthrough to mass-produce cultured red blood cells to develop new sourcing for blood transfusion. Supporting and complementing regular blood donation, this medical product will improve the quality of life of multi-transfused patients who suffer from hereditary or acquired diseases of the red blood cells in particular
DBMR has published a market research report on the Stem Cell Therapy market considering the changes in the market dynamics owing to the COVID-19 pandemic. The report covers a detailed overview of the historic events and the latest developments that have shaped the market forecast till 2027.
Self-renewal and specialization are two opposing functions in progenitor cells. Scientists resolve the mechanisms behind the opposing developmental actions of beta-catenin, a co-activator of the established molecular Wnt signaling pathway, that paradoxically regulates both self-renewal and specialization of mammalian progenitor cells destined to become kidney cells. The new study led by Andrew McMohan, PhD, chair of the department of stem cell biology and regenerative medicine at the Keck School of Medicine of University of Southern California, reports high levels of beta-catenin trigger a switch in part of the Wnt pathway that relies on transcription factors known as TCF/LEF
Market Industry Reports (MIR) has published a new report titled Stem Cell Assay Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 20192030. According to the report the global stem cell assay market was valued at over US$ 450.0 Mn
CLEVELAND -- (BUSINESS WIRE)-- Athersys, Inc. (Nasdaq: ATHX) announced today that its partner HEALIOS K.K
Researchers from the University of Science and Technology of China (USTC) of the Chinese Academy of Science (CAS), teamed up with scientists from Aix Marseille University, discovered that hematopoietic progenitors possessed the differentiation potential to type 1 innate lymphoid cells (ILC1s) in adult liver, and dissected the regulation mechanisms of such cell differentiation, revealing the pathways that lead to the development of tissue-resident lymphocytes. This study was published in Science
Recent Comments